Navidea Biopharmaceutical Stock (OTC: NAVB) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 2.796K / 108.420K |
Day Range | - - - |
52 Wk Range | 0.021 - 0.276 |
Market Cap | $3.813M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | OTC |
RSI | 0 |
Short Interest | - |
Days to Cover | 2.95 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Navidea Biopharmaceutical (OTCPK: NAVB) through any online brokerage.
There are no as such competitors for Navidea Biopharmaceutical.
The latest price target for Navidea Biopharmaceutical (OTCPK: NAVB) was reported by HC Wainwright & Co. on Monday, August 17, 2020. The analyst firm set a price target for 8.00 expecting NAVB to rise to within 12 months (a possible 20897.38% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Navidea Biopharmaceutical (OTCPK: NAVB) is $0.0381 last updated Today at April 26, 2024 at 1:08 PM EDT.
There are no upcoming dividends for Navidea Biopharmaceutical.
Navidea Biopharmaceutical’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Navidea Biopharmaceutical.
Navidea Biopharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.